BR112020018925A2 - Composições não hormonais e métodos para contracepção masculina - Google Patents

Composições não hormonais e métodos para contracepção masculina Download PDF

Info

Publication number
BR112020018925A2
BR112020018925A2 BR112020018925-1A BR112020018925A BR112020018925A2 BR 112020018925 A2 BR112020018925 A2 BR 112020018925A2 BR 112020018925 A BR112020018925 A BR 112020018925A BR 112020018925 A2 BR112020018925 A2 BR 112020018925A2
Authority
BR
Brazil
Prior art keywords
composition
alpha
silodosin
contraception
administration
Prior art date
Application number
BR112020018925-1A
Other languages
English (en)
Portuguese (pt)
Inventor
Guillaume El Glaoui
Mehdi El Glaoui
Philippe Perrin
Stéphane DROUPY
Véronique AGATHON-MERIAU
Original Assignee
Laboratoires Major
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Major filed Critical Laboratoires Major
Publication of BR112020018925A2 publication Critical patent/BR112020018925A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
BR112020018925-1A 2018-03-23 2019-03-22 Composições não hormonais e métodos para contracepção masculina BR112020018925A2 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862763129P 2018-03-23 2018-03-23
US62/763,129 2018-03-23
EP18305328 2018-03-23
EP18305328.9 2018-03-23
PCT/EP2019/057267 WO2019180217A1 (en) 2018-03-23 2019-03-22 Non-hormonal compositions and methods for male contraception

Publications (1)

Publication Number Publication Date
BR112020018925A2 true BR112020018925A2 (pt) 2020-12-29

Family

ID=65955198

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112020018925-1A BR112020018925A2 (pt) 2018-03-23 2019-03-22 Composições não hormonais e métodos para contracepção masculina

Country Status (19)

Country Link
US (3) US10912762B2 (https=)
EP (2) EP3750538B1 (https=)
JP (1) JP7270901B2 (https=)
KR (1) KR102496504B1 (https=)
CN (1) CN112074269A (https=)
AU (1) AU2019237228B2 (https=)
BR (1) BR112020018925A2 (https=)
CA (1) CA3094016C (https=)
DK (2) DK3562485T3 (https=)
ES (2) ES2989170T3 (https=)
FI (1) FI3750538T3 (https=)
IL (1) IL277372B2 (https=)
MA (1) MA53626B1 (https=)
MX (1) MX2020009937A (https=)
PL (2) PL3562485T3 (https=)
PT (1) PT3562485T (https=)
SG (1) SG11202008794TA (https=)
UA (1) UA128502C2 (https=)
WO (1) WO2019180217A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3750538B1 (en) * 2018-03-23 2024-08-14 Pharmajor International Non-hormonal methods for male contraception comprising (r)-silodosin
IL319287A (en) 2022-11-23 2025-04-01 Pharmajor Incorporated Silodosin formulations with different release and their use in male contraceptive methods

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1091276A (en) 1911-12-09 1914-03-24 Basf Ag Producing unsaturated terpene hydrocarbons.
US4210644A (en) 1978-02-23 1980-07-01 The Johns Hopkins University Male contraception
DE4308406C1 (de) 1993-03-12 1994-06-16 Jenapharm Gmbh Kombinationspräparat zur Kontrazeption
ATE474580T1 (de) 2000-02-15 2010-08-15 Bayer Schering Pharma Ag Zusammensetzung zur männlichen kontrazeption, norethisteron enthaltend
FR2861990B1 (fr) * 2003-11-10 2006-02-10 Nouveaux Produits Pharma Comprimes faiblement doses a reseau de polymeres
UA95085C2 (ru) * 2005-09-29 2011-07-11 Баер Шеринг Фарма Акциенгезельшафт Применение варденафила для лечения урологических расстройств
JP2009509984A (ja) * 2005-09-29 2009-03-12 バイエル・ヘルスケア・アクチェンゲゼルシャフト 泌尿器系障害の処置用のｐｄｅ阻害剤およびそれらの組合せ
US20100098735A1 (en) * 2006-10-05 2010-04-22 Rajesh Jain Injectable depot compositions and its process of preparation
GB0700893D0 (en) 2007-01-17 2007-02-21 King S College London Male contraceptive
MX2009009230A (es) 2007-02-28 2009-11-26 Kissei Pharmaceutical Uso de silodosina en una administracion diaria para tratar hiperplasia prostatica benigna.
US20120184591A1 (en) * 2011-01-13 2012-07-19 Watson Pharmaceuticals, Inc. Methods for treating prostatitis
CN102283816B (zh) * 2011-08-05 2013-09-11 北京海步国际医药科技发展有限公司 西洛多辛缓释片剂及其制备方法
WO2014118606A2 (en) * 2013-01-29 2014-08-07 Alembic Pharmaceuticals Limited A novel process for the preparation of silodosin
WO2016051782A1 (ja) 2014-09-30 2016-04-07 キッセイ薬品工業株式会社 苦味を有する薬剤の苦味をマスキングした経口投与製剤
US20170049834A1 (en) * 2015-08-18 2017-02-23 Golden Biotechnology Corporation Benign prostatic hyperplasia add-on therapy
EP3750538B1 (en) * 2018-03-23 2024-08-14 Pharmajor International Non-hormonal methods for male contraception comprising (r)-silodosin

Also Published As

Publication number Publication date
AU2019237228B2 (en) 2023-06-08
US10912762B2 (en) 2021-02-09
US11583518B2 (en) 2023-02-21
US20210113526A1 (en) 2021-04-22
NZ767741A (en) 2024-11-29
MX2020009937A (es) 2022-09-30
US11951095B2 (en) 2024-04-09
EP3562485A1 (en) 2019-11-06
RU2020134408A3 (https=) 2022-04-29
ES2989170T3 (es) 2024-11-25
JP7270901B2 (ja) 2023-05-11
US20230145374A1 (en) 2023-05-11
IL277372B1 (en) 2023-05-01
EP3562485B8 (en) 2020-08-19
PT3562485T (pt) 2020-08-27
SG11202008794TA (en) 2020-10-29
RU2020134408A (ru) 2022-04-29
FI3750538T3 (fi) 2024-09-24
MA53626A (fr) 2022-03-09
EP3750538B1 (en) 2024-08-14
ES2813084T3 (es) 2021-03-22
AU2019237228A1 (en) 2020-10-01
CA3094016C (en) 2023-10-10
DK3562485T3 (da) 2020-08-24
EP3750538A1 (en) 2020-12-16
PL3750538T3 (pl) 2024-11-25
KR102496504B1 (ko) 2023-02-06
MA53626B1 (fr) 2024-09-30
WO2019180217A1 (en) 2019-09-26
UA128502C2 (uk) 2024-07-31
IL277372B2 (en) 2023-09-01
KR20200135978A (ko) 2020-12-04
CA3094016A1 (en) 2019-09-26
CN112074269A (zh) 2020-12-11
JP2021518438A (ja) 2021-08-02
IL277372A (en) 2020-11-30
PL3562485T3 (pl) 2020-11-16
DK3750538T3 (da) 2024-09-23
EP3562485B1 (en) 2020-07-01
US20190290615A1 (en) 2019-09-26

Similar Documents

Publication Publication Date Title
US6124337A (en) Methods and formulations for modulating the human sexual response
RU2611403C1 (ru) Составы в форме спрея для перорального введения и способы введения силденафила
WO2014024193A1 (en) Compositions and methods for rapid transmucosal delivery of pharmaceutical ingredients
BR112020003380A2 (pt) formulações farmacêuticas para o tratamento de endometriose, miomas uterinos, síndrome do ovário policístico ou adenomiose
US11951095B2 (en) Non-hormonal compositions and methods for male contraception
AU749703B2 (en) Combination therapy for modulating the human sexual response
JPH05509293A (ja) 不整脈および発作の治療における５―ｈｔ４受容体拮抗剤の使用
RU2799756C2 (ru) Применение композиции для негормональной контрацепции и упаковка
HK40041318A (en) Non-hormonal methods for male contraception comprising (r)-silodosin
HK40041318B (en) Non-hormonal methods for male contraception comprising (r)-silodosin
OA21941A (en) Non-hormonal compositions and methods for male contraception.
US20240342155A1 (en) Hydroxychloroquine formulations, dosage forms, and methods of use
US20240180871A1 (en) Modified-release silodosin compositions and use thereof in methods for male contraception
US8003652B2 (en) Use of acetyl L-carnitine in combination with propionyl L-carnitine and Sildenafil for the treatment of erectile dysfunction
US20100311785A1 (en) Combination Therapy For Modulating The Human Sexual Response
WO2017100324A1 (en) Combination therapy for treating female hypoactive sexual desire disorders
CN119280196A (zh) 一种含伐地那非的口溶膜组合物及其应用
MXPA99010400A (en) Combination therapy for modulating the human sexual response

Legal Events

Date Code Title Description
B350 Update of information on the portal [chapter 15.35 patent gazette]
B25D Requested change of name of applicant approved

Owner name: PHARMAJOR (FR)

B25A Requested transfer of rights approved

Owner name: PHARMAJOR INTERNATIONAL (LU)

B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]